Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry

Progress in Polymer Science

Volumn 38, Issue 7, 2013, Pages 993-1008

  Mignani, Serge ^a   Kazzouli, Saïd El ^b   Bousmina, Mosto ^c,d   Majoral, Jean Pierre ^e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b MOHAMMED V UNIVERSITY   (Morocco)

^c Euro Mediterranean University of Fes (UEMF)   (Morocco)

^d HASSAN II ACADEMY OF SCIENCE AND TECHNOLOGY   (Morocco)

^e LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

Author keywords

Chemical space; Dendrimer space concept; Drug delivery; Druggable compounds; Nanomedicine

Indexed keywords

AIR NAVIGATION; BIOACTIVITY; DENDRIMERS; DRUG DELIVERY; DRUG PRODUCTS; FUNCTIONAL POLYMERS; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; METAL NANOPARTICLES; NANOMAGNETICS; RECOMBINANT PROTEINS; SPACE PLATFORMS; TARGETED DRUG DELIVERY;

BIOLOGICALLY ACTIVE COMPOUNDS; BIOMEDICAL APPLICATIONS; CHEMICAL SPACE; DRUG DISCOVERY PROCESS; DRUGGABLE COMPOUNDS; PHYSICOCHEMICAL PROPERTY; SPACE CONCEPT; TOPOLOGICAL CHARACTERISTICS;

CONTROLLED DRUG DELIVERY;

EID: 84878895972     PISSN: 00796700     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.progpolymsci.2013.03.003     Document Type: Review

References (203)

1. N.A. Ochekp, P.O. Olorunfemi, and N.C. Ngwuluka Nanotechnology and drug delivery. Part I: background and applications Tropical Journal of Pharmaceutical Research 8 2009 265 274
2. N.A. Ochekpe, P.O. Olorunfemi, and N.C. Ngwuluka Nanotechnology and drug delivery. Part 2: nanostructures for drug delivery Tropical Journal of Pharmaceutical Research 8 2009 275 287
3. S.D. Caruthers, S.A. Wickline, and G.M. Lanza Nanotechnological applications in medicine Current Opinion in Biotechnology 18 2007 6 30
4. M.M. Amiji Nanotechnology improving. Targeted delivery Drug Delivery 17 2007 53 56
5. R.A. Freitas What is nanomedicine? Nanomedicine: Nanotechnology, Biology and Medicine 1 2005 2 9
6. R. Duncan, and R. Gaspar Nanomedicine(s) under the microscope Molecular Pharmaceutics 8 2011 2101 2141
7. J. Ogier, T. Arnauld, and E. Doris Recent advances in the field of nanometric drug carriers Future Medicinal Chemistry 1 2009 693 711
8. P. Suphiya, R. Misra, and S.K. Sahoo Nanoparticles: a boon to drug delivery therapeutics diagnostics and imaging Nanomedicine: Nanotechnology, Biology and Medicine 8 2012 147 166
9. M. Ferrari Cancer nanotechnology: opportunities and challenges Nature Reviews Cancer 5 2005 161 171
10. L.K. Wolf Personalizing nanomedicine Chemical and Engineering News 89 39 2011 29 32
11. N. Ahmed, H. Fessi, and A. Elaissari Theranostic applications of nanoparticles in cancer Drug Discovery Today 17 2012 928 934
12. A.K. Singh, M.A. Hahn, L.G. Gutwein, M.C. Rule, J.A. Knapik, B.M. Moudgil, S.R. Grobmyer, and S.C. Brown Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy International Journal of Nanomedicine 7 2012 2739 2750
13. S. Svenson Dendrimers as versatile platform in drug delivery applications European Journal of Pharmaceutics and Biopharmaceutics 71 2009 445 462
14. T. Garg, O. Singh, S. Arora, and M.S.R. Murthy Dendrimer: a novel scaffold for drug delivery International Journal of Pharmaceutical Sciences Review and Research 7 2011 211 220
15. M.J. Cloninger Biological applications of dendrimers Current Opinion in Chemical Biology 6 2002 742 748
16. P. Kumar, K.P. Meena, P. Kumar, C. Choudhary, D.S. Thakur, and P. Bajpayee Dendrimer: a novel polymer for drug delivery Journal of Innovative Trends in Pharmaceutical Sciences 1 2010 252 269
17. H.V. Chavda Dendrimers: polymers of 21st century Pharmacological Reviews 5 2007 E.65 Online only: http://www.pharmainfo.net/reviews/dendrimers-polymers- 21-st-century (accessed February 2013).
18. E. Buhleier, W. Wehner, and F. Vögtle "Cascade"-and "Nonskid-Chain-like" syntheses of molecular cavity topologies Synthesis 2 1978 155 158
19. F. Vögtle, G. Richardt, and N. Werner Dendrimer Chemistry 2009 Wiley-VCH Weinbaden 354
20. M.A. Mintzer, and M.W. Grinstaff Biomedical applications of dendrimers: a tutorial Chemical Society Reviews 40 2010 173 190
21. D. Astruc, E. Boisselier, and C. Omelas Dendrimers designed for functions: from physical photophysical and supramolecular properties to applications in sensing catalysis molecular electronics photonics and nanomedicine Chemical Reviews 110 2010 1857 1959
22. A.R. Menjoge, R.M. Kannan, and D.A. Tomalia Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications Drug Discovery Today 15 2010 171 185
23. S. El Kazzouli, S. Mignani, M. Bousmina, and J.P. Majoral Dendrimer therapeutics: covalent and ionic attachments New Journal of Chemistry 36 2012 227 240
24. A.M. Caminade, C.O. Turrin, and J.P. Majoral Biological properties of phosphorus dendrimers New Journal of Chemistry 34 2010 1512 1524
25. E.R. Gillies, and J.M. Fréchet Dendrimers and dendritic polymers in drug delivery Drug Discovery Today 10 2005 35 42
26. B.K. Nanjwade, H.M. Bechra, G.K. Derkar, F.V. Manvi, and V.K. Nanjwade Dendrimers: emerging polymers for drug-delivery systems European Journal of Pharmaceutical Sciences 38 2009 185 196
27. J.B. Wolinsky, W. Mark, and M. Grinstaff Therapeutic and diagnostic applications of dendrimers for cancer treatment Advanced Drug Delivery Reviews 60 2008 1037 1055
28. Z. Sideratou, L.A. Tziveleka, C. Kontoyianni, D. Tsiourvas, and C.M. Paleo Design of functional dendritic polymers for application as drug and gene delivery systems Gene Therapy & Molecular Biology 10 2006 71 94
29. J. Khandare, M. Calderon, N.M. Dagia, and R. Haag Multifunctional dendritic polymers in nanomedicine: opportunities and challenges Chemical Society Reviews 41 2012 2824 2848
30. S. Gupta, R. Tyagi, V.S. Parmar, S.K. Sharma, and R. Haag Polyether based amphiphiles for delivery of active compounds Polymer 53 2012 3053 3078
31. J. Hu, M. Fang, Y. Cheng, J. Zhang, Q. Wu, and T. Xu Host-guest of dendrimer-drug complexes. An in-depth look into the binding/encapsulation of guanosine monophosphate by dendrimers Journal of Physical Chemistry 114 2010 7148 7157
32. R.B. Kolhatkar, P. Swaan, and H. Ghandehari Potential oral delivery of 7-ethyl-10-hydroxy-camptothecin (SN-38) using poly(amidoamine) dendrimers Pharmaceutical Research 25 2008 1723 1729
33. S.H. Medina, and M.E.H. El-Sayed Dendrimers as carriers for delivery of chemotherapeutic agents Chemical Reviews 109 2009 3141 3157
34. Anonymous. Bio Dendrimers International SA. http://www.biodendrimers.com [accessed Febraury 2013, 2010].
35. C.C. Anajwala, G.K. Jani, and S.M.V. Swamy Current trends of nanotechnology for cancer therapy International Journal of Pharmaceutical Sciences and Nanotechnology 3 2010 1043 1056
36. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
37. D.A. Tomalia, L.A. Reyna, and S. Svenson Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging Biochemical Society Transactions, Biochemical Society Transactions 35 2007 61 67
38. N.K. Jain, and U. Gupta Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability Expert Opinion on Drug Metabolism and Toxicology 4 2008 1035 1051
39. J.R. Baker Dendrimer-based nanoparticles for cancer therapy Nanotechnology for Hematology 1 2009 708 719
40. L.M. Kaminskas, V.M. McLeod, C.J.H. Porter, and B.J. Boyd Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation Molecular Pharmaceutics 9 2012 355 373
41. M. Avital-Shmilovici, and D. Shabat Self immolative dendrimers: a distinctive approach to molecular amplification Soft Matter 6 2010 1073 1080
42. E. Fleige, M.A. Quadir, and R. Haag Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications Advanced Drug Delivery Reviews 64 2012 866 884
43. K. Jain, P. Kesharwani, U. Gupta, and N.K. Jain Dendrimer toxicity: let's meet the challenge International Journal of Pharmaceutics 394 2010 122 142
44. V. Mishra, U. Gupta, and N.K. Jain Surface-engineered dendrimers: a solution for toxicity issues Journal of Biomaterials Science 20 2009 141 166
45. R. Duncan, and L. Izzo Dendrimer biocompatibility and toxicity Advanced Drug Delivery Reviews 57 2005 2215 2237
46. D.Q. McNermy, P.R. Leroueil, and J.R. Baker Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals Nanomedicine and Nanobiotechnology 2 2010 249 259
47. W. Wijagkanalan, S. Kawakami, and M. Hashida Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations Pharmaceutical Research 28 2011 1500 1519
48. C.C. Lee, J.A. MacKay, J.M. Fréchet, and F.C. Szoka Designing dendrimers for biological applications Nature Biotechnology 23 2005 1517 1526
49. H. Kobayashi, S. Kawamoto, S.K. Jo, H.L. Bryant, and M.W. Brechbiel Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores Bioconjugate Chemistry 14 2003 388 394
50. H.T. Chen, M.F. Neerman, A.R. Parrish, and E.E. Simanek Cytotoxicity hemolysis and acute in vivo toxicity of dendrimers based on melamine candidate vehicles for drug delivery Journal of the American Chemical Society 126 2004 10044 10048
51. M.F. Neerman, W. Zhang, A.R. Parrish, and E.E. Simanek In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery International Journal of Pharmaceutics 281 2004 129 132
52. B. Ziemba, A. Janaszewska, K. Ciepluch, M. Krotewicz, W.A. Fogel, D. Appelhans, B. Voit, M. Bryszewska, and B. Klajnert In vivo toxicity of poly(propyleneimine) dendrimers Journal of Biomedical Materials Research Part A 99 2011 261 268
53. A.S. Chauhan, N.K. Jain, and P.V. Diwan Pre-clinical and behavioural toxicity profile of PAMAM dendrimers in mice Proceedings of the Royal Society A 466 2010 1535 1550
54. Anonymous VivaGelÒ. http://www.starpharma.com/vivagel [accessed February 2013, 2012].
55. T.D. McCarthy, P. Karellas, S.A. Henderson, M. Giannis, D.F. O'Keefe, G. Heery, J.R.A. Paull, B.R. Matthews, and G. Holan Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention Molecular Pharmacology 2 2005 312 318
56. B. Misselwitz, H. Schmitt-Willich, W. Ebert, T. Frenzelet, and H.J. Weinmann Pharmacokinetics of Gadomer-17 a new dendritic magnetic resonance contrast agent Magnetic Resonance Materials in Physics, Biology and Medicine 12 2011 128 134
57. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Advanced Drug Delivery Reviews 23 1997 3 25
58. C.A. Lipinski, and A. Hopkins Navigating chemical space for biology and medicine Nature 432 2004 855 861
59. R.S. Bohacek, C. McMartin, and W.C. Guida The art and practice of structure-based drug design: a molecular modeling perspective Medicinal Research Reviews 16 1996 3 50
60. A.H. Lipkus, Q. Yuan, K.A. Lucas, S.A. Funk, W.F. Bartelt, R.J. Schenck, and A.J. Trippe Structural diversity of organic chemistry. A scaffold analysis of the CAS registry Journal of Organic Chemistry 73 2008 4443 4451
61. J.L. Reymond, L.C. Bluma, and R. van Deursen Exploring the chemical space of known and unknown organic small molecules at www.gdb.unibe.ch Chimia 65 2011 863 867
62. J.L. Reymond, R. van Deursen, L.C. Blum, and L. Ruddigkeit Chemical space as a source for new drugs Medicinal Chemistry Communications 1 2010 30 38
63. J.L. Reymond, L. Ruddigkeit, L. Blum, and R. Van Deursen The enumeration of chemical space Computational Molecular Science 2 2011 717 733
64. S.J. Haggarty The principle of complementarity: chemical versus biological space Current Opinion in Chemical Biology 9 2005 296 303
65. M. Vieth, J.J. Sutherland, D.H. Robertson, and R.M. Campbell Kinomics: characterizing the therapeutically validated kinase space Drug Discovery Today 10 2005 839 846
66. N.T. Southall Kinase patent space visualization using chemical replacements Journal of Medicinal Chemistry 49 2006 2103 2109
67. N. Singh, H. Sun, S. Chaudhury, M.D.M. AbdulHameed, A. Wallqvist, and G.A. Tawa Physicochemical descriptor-based scoring scheme for effective and rapid filtering of kinase-like chemical space Journal of Cheminformatics 4 2012 1 12
68. M. Sodeoka Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition Journal of Medicinal Chemistry 44 2001 3216 3222
69. P. Jimonet, and R. Jager Strategies for designing GPCR-focused libraries and screening sets Current Opinion in Drug Discovery & Development 7 2004 325 333
70. R.C. Reid Countering cooperative effects in protease inhibitors using constrained beta-strand mimicking templates in focused combinatorial libraries Journal of Medicinal Chemistry 47 2004 1641 1651
71. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple Molecular properties that influence the oral bioavailability of drug candidates Journal of Medicinal Chemistry 45 2002 2615 2623
72. P.D. Leeson, and A.M. Davis Time-related differences in the physical property profiles of oral drugs Journal of Medicinal Chemistry 47 2004 6338 6348
73. S.J. Teague, A.M. Davis, P.D. Leeson, and T.I. Oprea The design of lead like combinatorial libraries Angewandte Chemie International Edition 38 1999 3743 3748
74. T.I. Oprea, A.M. Davis, S.J. Teague, and P.D. Lesson Is there a difference between leads and drugs? A historical perspective Journal of Chemical Information and Computer Sciences 41 2001 1308 1315
75. T.I. Opera Current trends in lead discovery: are we looking for the appropriate properties Journal of Computer-Aided Molecular Design 16 2002 325 334
76. G.M. Makara On sampling of fragment space Journal of Medicinal Chemistry 50 2007 3214 3221
77. J. Pärn, J. Degenet, and M. Rarey Exploring fragment spaces under multiple physicochemical constraints Journal of Computer-Aided Molecular Design 21 2007 327 340
78. J. Rosén, J. Gottfries, S. Muresan, A. Backlund, and T.I. Oprea Novel chemical space exploration via natural products Journal of Medicinal Chemistry 52 2009 1953 1962
79. H. Lachance, S. Wetzel, K. Kumar, and H. Waldmann Charting navigating and populating natural product chemical space for drug discovery Journal of Medicinal Chemistry 9 2009 1953 1962
80. M. Boehm Virtual screening of Chemical Space: From Generic Compound Collections to Tailored Screening Libraries C. Sotriffer, Virtual Screening: Principles Challenges and Practical Guidelines 2011 Wiley-VCH Weinbaden 3 34
81. G.M. Keserü, and G.M. Makara The influence of lead discovery strategies on the properties of drug candidates Nature Reviews Drug Discovery 8 2009 203 212
82. M.M. Hann, and G.M. Keserü Finding the sweet spot: the role of nature and nurture in medicinal chemistry Nature Reviews Drug Discovery 11 2012 355 365
83. X. Morelli, R. Bourgeas, and P. Roche Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I) Current Opinion in Chemical Biology 15 2011 1 7
84. G.R. Bickerton, G.V. Paolini, J. Besnard, S. Muresan, and A.L. Hopkins Quantifying the chemical beauty of drugs Nature Chemistry 4 2012 90 98
85. A. Nadin, C. Hattotuwagama, and I. Churcher Lead-oriented synthesis: a new opportunity for synthetic chemistry Angewandte Chemie International Edition 51 2012 2 11
86. Y.B. Choy, and M.R. Prausnitz The rule of five for non-oral routes of drug delivery: ophthalmic inhalation and transdermal Pharmaceutical Research 28 2011 943 948
87. H. Kubinyi Chance favors the prepared mind - from serendipity to rational drug design Journal of Receptors and Signal Transduction Research 19 1999 15 39
88. C.G. Kruse, and H. Timmerman Towards Drugs of the Future: Key Issues in Lead Finding and Lead Optimization 2008 IOS Press Amsterdam 129
89. A.C. Rigby Exploring novel chemical space through the use of computational and structural biology Combinatorial Chemistry and High Throughput Screening 12 2009 927 928
90. M. Dow, M. Fisher, T. James, F. Marchetti, and A. Nelson Towards the systematic exploration of chemical space Organic & Biomolecular Chemistry 10 2012 17 28
91. T.I. Oprea, and J. Gottfries Chemography: the art of navigating in chemical space Journal of Combinatorial Chemistry 3 2001 157 166
92. T.I. Oprea Chemical space navigation in lead discovery Current Opinion in Chemical Biology 6 2002 384 389
93. J. Clardy, and C. Walsh Lessons from natural molecules Nature 432 2004 829 837
94. A. Reayi, and P. Arya Natural product-like chemical space: search for chemical dissectors of macromolecular interactions Current Opinion in Chemical Biology 9 2005 240 247
95. M. Famulok Exploring space with aptamers Journal of Medicinal Chemistry 52 2009 6951 6957
96. B.K. Shoichet Virtual screening of chemical libraries Nature 432 2004 862 865
97. W.P. van Hoorn, and A.S. Bell Searching chemical space with the Bayesian Idea Generator Journal of Chemical Information and Modeling 49 2009 2211 2220
98. T. Fink, and J.L. Reymond Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery Journal of Chemical Information and Modeling 47 2007 342 353
99. L.C. Blum, R. van Deursen, and J.L. Reymond Visualisation and subsets of the chemical universe database GDB-13 for virtual screening Journal of Computer-Aided Molecular Design 25 2011 637 647
100. L.C. Blum, and J.L. Reymond 970 Million drug like small molecules for virtual screening in the chemical universe database GDB-13 Journal of the American Chemical Society 131 2009 8732 8733
101. C. Abad-Zapatero Ligand efficiency indices for effective drug discovery Expert Opinion on Drug Discovery 2 2007 469 488
102. S. Braggio, D. Montanari, T. Rossi, and E. Ratti Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates Expert Opinion on Drug Discovery 5 2010 609 618
103. C. AbadZapatero, O. Perisic, J. Wass, A.P. Bento, J. Overington, B. Al-Lazikani, and M.E. Johnson Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation Drug Discovery Today 15 2010 804 811
104. A.M. Caminade, and J.P. Majoral Water soluble phosphorus-containing dendrimers Progress in Polymer Science 30 2005 491 505
105. L. Griffe, M. Poupot, P. Marchand, A. Maraval, C.O. Turrin, O. Rolland, P. Metivier, G. Bacquet, J.J. Fournie, A.M. Caminade, R. Poupot, and J.P. Majoral Multiplication of human natural killer cells by nanosized phosphonate-capped dendrimers Angewandte Chemie International Edition 46 2007 2523 2526
106. O. Rolland, L. Griffe, M. Poupot, A. Maraval, A. Ouali, Coppel y, J.J. Fournie, G. Bacquet, C.O. Turrin, A.M. Caminade, J.P. Majoral, and R. Poupot Tailored control and optimisation of the number of phosphonic acid termini on phosphorus-containing dendrimers for the ex-vivo activation of human monocytes Chemistry: A European Journal 14 2008 4836 4850
107. A.V. Maksimenko, V. Mandrouguine, M.B. Gottikh, J.R. Bertrand, J.P. Majoral, and C. Malvy Optimisation of dendrimer-mediated gene transfer by anionic oligomers Journal of Gene Medicine 5 2003 61 71
108. G. Spataro, F. Malecaze, C.O. Turrin, V. Soler, C. Duhayon, P.P. Elena, J.P. Majoral, and A.M. Caminade Designing dendrimers for ocular drug delivery European Journal of Medical Chemistry 45 2010 326 334
109. R.K. Thatavarathy, M. Parent, M.V.H. Werts, L. Moreaux, S. Gmouh, S. Charpak, A.M. Caminade, J.P. Majoral, and M. Blanchard-Desce Water-soluble dendrimeric two-photons tracers for In vivo imaging Angewandte Chemie International Edition 45 2006 4645 4648
110. M. Hayder, M. Poupot, M. Baron, D. Nigon, C.O. Turrin, A.M. Caminade, J.P. Majoral, R.A. Eisenberg, J.J. Fournie, A. Cantagrel, R. Poupot, and J.L. Davignon A Phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis Science Translational Medicine 3 81ra35/ 2011 1 11
111. C.B. Yim, O.C. Boerman, M. de Visser, M. de Jong, A.C. Dechesne, D.T. Rijkers, and R.M. Liskamp Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers Bioconjugate Chemistry 20 2009 1323 1331
112. J.C. Spetzler, and J.P. Tam Self-assembly of cyclic peptides on a dendrimer: multiple cyclic antigen peptides Peptide Research 9 1996 290 296
113. C. Dufès, I. Uchegbu, and A.G. Schätzlein Dendrimers in gene delivery Advanced Drug Delivery Reviews 57 2005 2177 2202
114. C. Padié, M. Maszewska, K. Majchrzak, B. Nawrot, A.M. Caminade, and J.P. Majoral Polycationic phosphorus dendrimers: synthesis characterization study of cytotoxicity complexation of DNA and transfection experiments New Journal of Chemistry 33 2009 318 326
115. G.S. Yu, Y.M. Bae, H. Choi, B. Kong, I.S. Choi, and J.S. Choi Synthesis of PAMAM dendrimer derivatives with enhanced buffering capacity and remarkable gene transfection efficiency Bioconjugate Chemistry 22 2011 1046 1055
116. J. Haensler, C. Francis, and F.C. Szoka Polyamidoamine cascade polymers mediate efficient transfection of cells in culture Bioconjugate Chemistry 4 1993 372 379
117. A. Bielinska, J.F. Kukowska-Latallo, J. Johnson, D.A. Tomalia, and J.R. Baker Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers Nucleic Acids Research 24 1996 2176 2182
118. H. Yoo, P. Sazani, and R.L. Juliano PAMAM dendrimers as delivery agents for antisense oligonucleotides Pharmaceutical Research 16 1999 1799 1804
119. J.D. Eichman, A.U. Bielinska, J.F. Kukowska-Latallo, and J.R. Baker The use of PAMAM dendrimers in the efficient transfer of genetic material into cells Pharmaceutical Science & Technology Today 3 2000 232 245
120. X. Liu, H. Huang, J. Wang, C. Wang, M. Wang, B. Zhang, and C. Pan Dendrimers-delivered short hairpin RNA targeting hTERT inhibits oral cancer cell growth in vitro and in vivo Biochemical Pharmacology 82 2011 17 23
121. M.L. Patil, M. Zhang, and T. Minko Multifunctional triblock nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing ACS Nano 5 2011 1877 1887
122. A.C. Rodrigo, I. Rivilla, F.C. Pérez-Martínez, S. Monteagudo, V. Ocaña, J. Guerra, J.C. García-Martínez, S. Merino, P. Sánchez-Verdú, V. Ceña, and J. Rodríguez-López Efficient non-toxic hybrid PPV-PAMAM dendrimer as a gene carrier for neuronal cells Biomacromolecules 12 2011 1205 1213
123. J. Liu, J. Zhou, and Y. Luo SiRNA delivery systems based on neutral cross-linked dendrimers Bioconjugate Chemistry 23 2012 174 183
124. C. Wängler, G. Moldenhauer, M. Eisenhut, U. Haberkorn, and W. Mier Antibody-dendrimer conjugates: the number not the size of the dendrimers determines the immunoreactivity Bioconjugate Chemistry 19 2008 813 820
125. K. New, D.E. Milenic, G.L. Ray, Y.S. Kim, and M.W. Brechbiel Preparation of cystamine core dendrimer and anti-body-dendrimer conjugates for RMI angiography Molecular Pharmaceutics 9 2012 374 381
126. T.P. Thomas, A.K. Patri, A. Myc, M.T. Myaing, J.Y. Ye, T.B. Norris, and J.R. Baker In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles Biomacromolecules 5 2004 2269 2274
127. I.H. Lee, S. An, M.K. Yu, H.K. Kwon, S.H. Im, and S. Jon Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates Journal of Controlled Release 7 2011 435 441
128. I. Posadas, B. López-Hernández, M.I. Clemente, J.L. Jiménez, P. Ortega, P.J. de la Mata, R. Gómez, M.A. Muñoz-Fernández, and V. Ceña Highly efficient transfection of rat cortical neurons using carbosilane dendrimers unveils a neuroprotective role for HIF-1alpha in early chemical hypoxia-mediated neurotoxicity Pharmaceutical Research 26 2009 1181 1191
129. J.B. Kim, J.S. Choi, K. Nam, M. Lee, J.S. Park, and J.K. Lee Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer PAMAM-Arg Journal of Controlled Release 114 2006 110 117
130. V. Gajbhiye, V.K. Palanirajan, R. Tekade, and N.K. Jain Dendrimers as therapeutic agents: a systematic review Journal of Pharmacy and Pharmacology 61 2009 989 1003
131. Y.M. Chabre, and R. Roy Dendrimer-coated carbohydrates as drug delivery Trojan horses in glycosciences Y.Y. Cheng, Dendrimer-based Drug delivery Systems: From Theory to Practice 2012 Wiley-VCH Weinheim 405 436
132. R. Roy, and T.C. Shiao Glycodendrimers as functional antigens and antitumorales vaccines New Journal of Chemistry 36 2012 324 339
133. Y.M. Chabre, and R.R. Roy Recent trends in glycodendrimer syntheses and applications Current Topics in Medicinal Chemistry 14 2008 1237 1285
134. M. Poupot, L. Griffe, P. Marchand, A. Maraval, O. Rolland, L. Martinet, F.E. L'Faqihi-Olive, C.O. Turrin, A.M. Caminade, J.J. Fournié, J.P. Majoral, and R. Poupot Design of phosphorylated dendritic architectures to promote human monocyte activation FASEB Journal 20 2006 2339 2351
135. A. D'Emanuel, R. Jevprasesphant, J. Penny, and D. Attwood The use of a dendrimer propranolol prodrug to bypass efflux transporters and enhance oral bioavailability Journal of Controlled Release 95 2004 447 453
136. R.S. Dhanikula, A. Argaw, J.F. Bouchard, and P. Hildgen Methotrexate loaded polyether- copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability Molecular Pharmaceutics 5 2008 105 116
137. P. Rajakumar, N. Venkatesan, K. Sekar, S. Nagaraj, and R. Rengasamy Synthesis and antioxidant properties of enone core based dendrimers with carbazole as surface group European Journal of Medical Chemistry 45 2010 1220 1224
138. Y. Cheng, Z. Xu, M. MA, and T. Xu Dendrimers as drug carriers: applications in different routes of drug administration Journal of Pharmaceutical Sciences 97 2008 123 143
139. V. Gajbhiye, P.V. Kumar, A. Sharma, A. Agarwal, A. Asthana, and N.K. Jain Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives Indian Journal of Pharmaceutical Sciences 70 2008 431 439
140. M. Sun, A. Fan, Z. Wang, and Y. Zhao Dendrimer-mediated drug delivery to the skin Soft Matter 8 2012 4301 4305
141. I. Zhang, F.X. Gu, J.M. Chan, A.Z. Wang, R.S. Langer, and O.C. Farokhzad Nanoparticles in medicine: therapeutic applications and developments Journal of Translational Medicine 5 2008 761 769
142. D.J. Triggle The chemist as astronaut: searching for biologically useful space in the chemical universe Biochemical Pharmacology 78 2009 217 223
143. S. Pérot, O. Sperandio, M.A. Miteva, A.C. Camproux, and B.O. Villoutreix Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery Drug Discovery Today 15 2010 656 667
144. S. Dandapani, and L.A. Marcaurelle Accessing new chemical space for 'undruggable' targets Nature Chemical Biology 6 2010 861 863
145. C. Kojima Design of stimuli-responsive dendrimers Expert Opinion on Drug Discovery 7 2010 307 319
146. R.R. Ramireddy, K.R. Raghupathi, D.A. Torres, and S. Thayumanavan Stimuli sensitive amphiphilic dendrimers New Journal of Chemistry 36 2012 340 349
147. J.A. Robinson, S. DeMarco, F. Gombert, K. Moehle, and D. Obrecht The design structures and therapeutic potential of protein epitope mimetics Drug Discovery Today 13 2008 944 951
148. G. Zinzalla, and D.E. Thurstoon Targeting protein-protein interactions for therapeutic intervention: a challenge for the future Future Medicinal Chemistry 1 2009 65 93
149. P.M. Fischer Peptide peptidomimetic and small-molecule antagonists of the p53-HDM2 protein-protein interaction International Journal of Peptide Research and Therapeutics 12 2006 3 19
150. S. Fletcher, and A.D. Hamilton Targeting protein-protein interactions by rational design: mimicry of protein surfaces Journal of the Royal Society Interface 3 2006 215 233
151. C.Z. Chen, N.C. Beck-Tan, P. Dhurjati, T.K. van Dyk, R.A. LaRossa, and S.L. Cooper Quaternary ammonium functionalized poly(propylene imine) dendrimers as effective antimicrobials: srtructure-activity studies Biomacromolecules 1 2000 473 480
152. C.Z. Chen, S.L. Cooper, and N.C.B. Tan Incorporation of dimethyldodecylammonium chloride functionalities onto poly(propylene imine) dendrimers significantly enhances their antibacterial properties Chemical Communications 1999 1585 1586
153. A.I. Lopez, R.Y. Reins, A.M. McDermott, B.W. Trautner, and C. Cai Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers Molecular BioSystems 5 2009 1148 1156
154. M.K. Calabretta, A. Kumar, A.M. McDermott, and C. Cai Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups Biomacromolecules 8 2007 1807 1811
155. W.R.S. Navath, A.R. Menjoge, B. Balakrishanan, R. Bellair, H. Dai, R. Romero, S. Kannan, and R.M. Kannan Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers International Journal of Pharmaceutics 395 2010 298 308
156. A. Castonguay, E. Ladd, T. van de Ven, and A. Kakkar Dendrimers as bactericides New Journal of Chemistry 36 2012 199 204
157. S.R. Meyers, F.S. Juhn, A.P. Griset, N.R. Luman, and M.W. Grinstaff Anionic amphiphilic dendrimers as antibacterial agents Journal of the American Chemical Society 130 2008 14444 14445
158. P. Rajakumar, K. Ganesan, S. Jayavelu, and K. Murugesan Synthesis and bactericidal efficacy of novel dendrimers Synlett 7 2005 1121 1124
159. P. Ortega, J.L. Copa-Patino, M.A. Munoz-Fernandez, J. Soliveri, R. Gomez, and J. Javier de la Mata Amine and ammonium functionalization of chloromethylsilane-endeddendrimers. Antimicrobial activity studies Organic & Biomolecular Chemistry 6 2008 3264 3269
160. P. Ortega, B.M. Cobaleda, J.M. Hernandez-Ros, E. Fuentes-Paniagua, J. Sanchez-Nieves, M.P. Tarazona, J.L. Copa-Patino, J. Soliveri, F. Javier de la Mata, and R. Gomez Hyperbranched polymers versus dendrimers containing a carbosilane framework and terminal ammonium groups as antimicrobial agents Organic & Biomolecular Chemistry 9 2011 5238 5248
161. P. Tam, Y.A. Lu, and J.L. Yang Antimicrobial dendrimeric peptides European Journal of Biochemistry 269 2002 923 932
162. N. Nagahori, R.T. Lee, S.I. Nishimura, D. Pagé, R. Roy, and Y.C. Lee Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands ChemBioChem 3 2002 836 844
163. M. Dubber, O. Sperling, and T.K. Linhorst Oligomannoside mimetics by glycosylation of 'octopus glycosides' and their investigation as inhibitors of type 1 fimbriae-mediated adhesion of Escherichia coli Organic & Biomolecular Chemistry 4 2006 3901 3912
164. Y.M. Chabre, D. Giguère, B. Blanchard, J. Rodrigue, S. Rocheleau, M. Neault, S. Rauthu, A. Papadopoulos, A. Arnold, A. Imberty, and R. Roy Combining glycomimetic and multivalent strategies toward designing potent bacterial lectin inhibitors Chemistry: A European Journal 17 2011 6545 6562
165. I. Deguise, D. Lagnoux, and R. Roy Synthesis of glycodendrimers containing both fucoside and galactoside residues and their binding properties to PA-IL and PA-IIL lectins from pseudomonas aeruginosa New Journal of Chemistry 31 2007 1321 1331
166. M. Touaibia, and R. Roy The First Synthesis of "Majoral-type" glycodendrimers bearing covalently bound a-d-mannopyranoside residues onto a hexachlorocyclo-triphosphazene core Journal of Organic Chemistry 73 2008 9292 9302
167. C.Y. Lee, A. Sharma, R.L. Uzarski, J.E. Cheong, H. Xu, R.A. Held, S.K. Upadhaya, and J.L. Nelson Potent antioxidant dendrimers lacking pro-oxidant activity Free Radical Biology and Medicine 50 2011 918 925
168. K. Ciepluch, N. Katir, A. El Kadib, A. Felczak, K. Zawadzka, M. Weber, B. Klajnert, K. Lisowska, A.M. Caminade, M. Bousmina, M. Bryszewska, and J.P. Majoral Biological properties of new viologen-phosphorus dendrimers Molecular Pharmaceutics 9 2012 448 457
169. G. Pérez-Anes, G. Spataro, C. Coppel, M. Moog, C. Blanzat, O. Turrin, A.M. Caminade, I. Rico-lattes, and J.P. Majoral Phosphonate terminated PPH dendrimers: influence of pendant alkyl chains on the in vitro anti-HIV-1 properties Organic & Biomolecular Chemistry 7 2009 3491 3498
170. S.K. Wang, P.H. Liang, R.D. Astronomo, T.I. Hsu, S.I. Hsieh, D.R. Burton, and C.H. Wong Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN Proceedings of the
171. S.H. Medina, V. Tekumalla, M.V. Cheliakov, D.S. Shewach, W.D. Ensminger, and M.E.H. El-Sayed N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers Biomaterials 32 2011 4118 4129
172. K.T. Al-Jamal, W.T. Al-Jamal, S. Akerman, J.E. Podesta, A. Yilmazer, J.A. Turton, A. Bianco, N. Vargesson, C. Kanthou, A.T. Florence, G.M. Tozer, and K. Kostarelos Systemic antiangiogenic activity of cationic poly-l-lysine dendrimer delays tumor growth Proceedings of the National Academy of Sciences of the United States of America 2 2010 3966 3971
173. S. Shaunak, S. Thomas, E. Gianasi, A. Godwin, E. Jones, I. Teo, K. Mireskandari, P. Luther, R. Duncan, S. Patterson, P. Khaw, and S. Brocchini Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation Nature Biotechnology 22 2004 977 984
174. T. Wasiak, M. Ionov, K. Nieznanski, H. Nieznanska, O. Klementieva, M. Granell, J. Cladera, J.P. Majoral, A.M. Caminade, and B. Klajnert Phosphorus dendrimers affect Alzheimer's (Ab1-28) peptide and MAP-Tau protein aggregation Molecular Pharmaceutics 9 2012 458 469
175. S. Kannan, H. Dai, R.S. Navath, B. Balahrishnan, A. Jyoti, J. Janisse, R. Romero, and R.M. Kannan Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model Science Translational Medicine 4 130ra46/ 2012 1 21
176. A.V. Pukin, H.M. Branderhorst, C. Sisu, C.A.G.M. Weijers, M.J. Gilbert, R.M. Liskamp, G.M. Visser, H. Zuilhof, and R.J. Pieters Strong inhibition of cholera toxin by multivalent GM1 derivatives ChemBioChem 8 2007 1500 1503
177. D. Paul, H. Miyake, S. Shinoda, and H. Tsukude Proteo-dendrimers designed for complementary recognition of cytochromec: dendrimer architecture toward nanoscale protein complexation Chemistry: A European Journal 12 2006 1328 1338
178. F. Chiba, T.C. Hu, L.J. Twyman, and M. Wagstaff Dendrimers as size selective inhibitors to protein-protein binding Chemical Communications 2008 4351 4353
179. C.M. Paleos, D. Tsiourvas, Z. Sideratou, and L.A. Tziveleda Drug delivery using multifunctional dendrimers and hyperbranched polymers Expert Opinion on Drug Delivery 7 2010 1387 1398
180. L. van Haandel, and J.F. Stoaugh Bioanalytical method development for a generation 5 polyamidoamine folic acid methotrexate conjugated nanoparticle Analytical and Bioanalytical Chemistry 397 2010 1841 1852
181. Y. Wang, R. Guo, X. Cao, M. Shen, and X. Shi Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy Biomaterials 32 2011 3322 3329
182. I.J. Majoros, A. Myc, and T. Thomas PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis characterization and functionality Biomacromolecules 7 2006 572 579
183. X. Bi, X. Shi, I.J. Majoros, R. Shukla, and J.R. Baker Multifunctional poly(amidoamine) dendrimer-Taxol conjugates: synthesis characterization and stability Journal of Computational and Theoretical Nanoscience 4 2007 1179 1187
184. S. Shukla, G. Wu, M. Chatterjee, W. Yang, M. Sekido, L.A. Diop, R. Müller, J.J. Sudimack, R.J. Lee, R.F. Barth, and W. Tjarks Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy Bioconjugate Chemistry 14 2003 158 167
185. R.F. Barth, D.M. Adams, A.H. Soloway, F. Alam, and M.V. Darby Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy Bioconjugate Chemistry 5 1994 58 66
186. W.G. Lesniak, M.S.T. Kariapper, and B.M. Nair Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting a v b 3 integrins Bioconjugate Chemistry 18 2007 1148 1154
187. K. Winnicka, K. Bielawski, and A. Bielawska Synthesis and cytotoxic activity of G3 PAMAM-NH2 dendrimer-modified digoxin and proscillaridin A conjugates in breast cancer cells Pharmacological Reports 62 2010 414 423
188. E.M.V. Johansson, J. Dubois, T. Darbre, and J.L. Reymond Glycopeptide dendrimer colchicine conjugates targeting cancer cells Bioorganic and Medicinal Chemistry 18 2010 589 6597
189. T.P. Thomas, S.K. Choi, M.H. Li, A. Kotlyar, and J.R. Baker Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery Bioorganic and Medicinal Chemistry Letters 20 2010 5191 5194
190. H. Gaertner, F. Cerini, A. Kamath, A.F. Rochat, C.A. Siegrist, L. Menin, and O. Harley Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles Bioconjugate Chemistry 22 2011 1103 1114
191. P.V. Kumar, A. Asthana, T. Dutta, and N.K. Jain Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers Journal of Drug Targeting 14 2006 546 556
192. X. Xu, Y. Zhang, X. Wang, X. Guo, X. Zhang, Y. Qi, and Y.M. Shen Radiosynthesis biodistribution and micro-SPECT imaging study of dendrimer-avidin conjugate Bioorganic and Medicinal Chemistry 19 2011 1643 1648
193. Y. Zhang, Y. Sun, X. Xu, H. Zhu, L. Huang, X. Zhang, Y. Qi, and Y.M. Shen Radiosynthesis and micro-SPECT imaging of 99mTc-dendrimer poly(amido)-amine folic acid conjugate Bioorganic and Medicinal Chemistry 20 2011 927 931
194. Y. Zhang, X. Sun, X. Xu, X. Zhang, H. Zhu, L. Huang, Y. Qi, and Y.M. Shen Synthesis biodistribution and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates Journal of Medicinal Chemistry 53 2010 3262 3272
195. B.D. Kurmi, V. Gajbhiye, J. Kayat, and N.K. Jain Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate Journal of Pharmaceutical Sciences 100 2011 2311 2320
196. D. Bhadra, A.K. Yadav, S. Bhadra, and N.K. Jain Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting International Journal of Pharmaceutics 295 2005 221 233
197. D. Chandrasekar, R. Sistla, F.J. Ahmad, R.K. Khar, and P.V. Diwan The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats Biomaterials 28 2007 504 512
198. H. He, Y. Li, X.R. Jia, J. Du, X. Ying, W.L. Lu, J.N. Lou, and Y. Wei PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors Biomaterials 32 2011 478 487
199. V. Gajbhiye, and N.K. Jain The treatment of glioblastoma xenografts by surfactant conjugated dendritic nanoconjugates Biomaterials 32 2011 6213 6225
200. R.K. Tekade, T. Dutta, A. Tyagi, A.C. Bharti, B.C. Das, and N.K. Jain Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy Journal of Drug Targeting 16 2008 758 772
201. C. Clementi, K. Miller, A. Mero, R. Satchi-Fainaro, and G. Pasut Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms Molecular Pharmaceutics 8 2011 1063 1072
202. R.S. Navath, A.R. Menjoge, B. Wang, R. Romero, S. Kannan, and R.M. Kannan Amino acid- functionalized dendrimers with hetero-bifunctional chemoselective peripheral groups for drug delivery Biomacromolecules 11 2010 1544 1563
203. D.K. Tosh, L.S. Yoo, M. Chinn, K. Hong, K.S.M. Kilbey, M.O. Barrett, I.P. Fricks, T.K. Harden, Z.G. Gao, and K.A. Jacobson Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotide Bioconjugate Chemistry 21 2010 372 384